Serum KIM-1 levels in NADKD patients are significantly higher than those in healthy controls (31), and KIM-1 levels increase with the progression of CKD (32), suggesting that KIM-1 can be used for diagnosing NADKD and disease severity. Here, HAVCR1 is linked to chronic kidney disease.